Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
While most physicians are skeptical AI will fully replace them in the future, many do believe the technology will be able to make prognoses and overtake some administrative tasks, according to a survey of 740 general physicians in the United Kingdom.
K Health, a New York-based health technology company, raised $25 million in a recent funding round for its AI-powered health app that checks symptoms and provides information about a user’s health, according to information available on Crunchbase.
The University of Guelph in Ontario, Canada, has launched a new center that aims to address the ethics of AI and build "machines with morals" by ensuring technologies benefit people and minimize harm.
San Francisco-based startup Myia Labs has raised $6.75 million in seed funding to further develop its patient-monitoring platform, according to Yahoo Finance.
Researchers with the Brigham and Women’s Hospital (BWH) in Boston have developed a device that uses AI to automatically detect signs of ovulation in women, according to a recent study. The device could mean a more cost-effective and accurate resource for women looking to plan or prevent pregnancy.
A majority of consumers have at least one social determinant of health (SDOH) challenge that could impact their care, according to a survey from medical billing service Waystar.
Four thousand California-based mental health workers with Kaiser Permanente went on strike this week to call attention to the need for more clinicians and better scheduling for patients.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.